Paris - Delayed Quote EUR

Innate Pharma S.A. (IPH.PA)

2.1500

-0.0100

(-0.46%)

At close: April 18 at 5:35 PM GMT+2

Currency in EUR All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

51,901.0000

49,580.0000

12,110.0000

56,155.0000

Cost of Revenue

3,042.0000

Gross Profit

53,791.0000

Operating Expense

64,570.0000

66,005.0000

59,937.0000

55,076.0000

Operating Income

-12,669.0000

-16,425.0000

-47,827.0000

1,079.0000

Net Non Operating Interest Income Expense

2,537.0000

258.0000

15.0000

223.0000

Other Income Expense

2,562.0000

-41,805.0000

2,330.0000

-2,131.0000

Pretax Income

-7,570.0000

-57,972.0000

-45,478.0000

-829.0000

Net Income Common Stockholders

-7,570.0000

-58,103.0000

-52,809.0000

-63,984.0000

Diluted NI Available to Com Stockholders

-7,570.0000

-58,103.0000

-52,809.0000

-63,984.0000

Basic EPS

-0.79

-0.09

-0.73

-0.66

-0.81

Diluted EPS

-0.79

-0.09

-0.73

-0.66

-0.81

Basic Average Shares

79,922.8260

80,453.2820

79,639.8260

79,542.6270

78,934.9600

Diluted Average Shares

79,922.8260

80,453.2820

79,639.8260

79,542.6270

78,934.9600

Total Operating Income as Reported

-12,669.0000

-57,425.0000

-47,825.0000

1,079.0000

Rent Expense Supplemental

1,702.0000

Total Expenses

64,570.0000

66,005.0000

59,937.0000

55,076.0000

Net Income from Continuing & Discontinued Operation

-7,570.0000

-58,103.0000

-52,809.0000

-63,984.0000

Normalized Income

-10,132.0000

-16,167.0000

-47,808.0000

1,302.0000

Interest Income

3,177.0000

546.0000

327.0000

564.0000

Interest Expense

640.0000

288.0000

312.0000

341.0000

Net Interest Income

2,537.0000

258.0000

15.0000

223.0000

EBIT

-6,930.0000

-57,684.0000

-45,166.0000

-488.0000

EBITDA

-1,839.0000

-12,279.0000

-40,570.0000

56,309.0000

Reconciled Cost of Revenue

3,042.0000

Reconciled Depreciation

5,091.0000

45,405.0000

4,596.0000

56,797.0000

Net Income from Continuing Operation Net Minority Interest

-7,570.0000

-57,972.0000

-45,478.0000

-829.0000

Total Unusual Items Excluding Goodwill

2,562.0000

-41,805.0000

2,330.0000

-2,131.0000

Total Unusual Items

2,562.0000

-41,805.0000

2,330.0000

-2,131.0000

Normalized EBITDA

-4,401.0000

29,526.0000

-42,900.0000

58,440.0000

12/31/2020 - 11/1/2006

Yahoo Finance Plus Essential access required. Unlock Access

GNFT.PA Genfit S.A.

3.1850

+0.31%

PHXM.PA PHAXIAM Therapeutics S.A.

2.9150

-1.19%

ALCLS.PA Cellectis S.A.

2.3650

+0.85%

ADOC.PA Adocia SA

8.41

-1.06%

POXEL.PA Poxel S.A.

0.6540

+6.34%

BIX0.F BioInvent International AB (publ)

1.8080

+2.49%

BIX0.DU BioInvent International AB

2.0050

+11.64%

30J.SG IDEAYA Biosciences, Inc.

34.80

-6.95%

OSE.PA OSE Immunotherapeutics SA

5.0000

+2.56%

6A3A.F Autolus Therapeutics plc

4.4800

-0.88%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Innate Pharma S.A. (IPH.PA)

Related Tickers